Enacted on December 29, 2022, the  Modernization of Cosmetics Regulation Act ("MoCRA") applies more of a drug-like regulatory framework to cosmetics. The landmark legislation significantly overhauls the Food and Drug Administration’s (“FDA”)... Read More
Articles | Drug and Device Advertising, Marketing & Promotion Legal Review | Intellectual Property Services | Manufacturers | Pharmaceutical Manufacturers | Regulatory Compliance, including FDA, DEA and HIPAA

Frier Levitt attorneys speak with prosecutors, Boards of Pharmacies, PBM auditors, wholesalers, and the like on a daily basis on behalf of pharmacies nationally. We regularly spot trends and report back to the industry. We are closely monitoring... Read More
All types of single and multi-specialty medical practice groups | Articles | Behavioral Health Practitioners | Biotech Companies | Chain Pharmacies | Community, Retail Pharmacies | Data Transactions | Digital Pharmacies | Drug and Device Advertising, Marketing & Promotion Legal Review | Federal and State Fraud and Abuse Counseling | Federal and State Fraud and Abuse Counseling | Healthcare Practice Compliance | Manufacturers | Pharmaceutical Manufacturers | Pharmaceutical Wholesalers | Physicians and Medical Practices of all Specialties | Professional Practice Representation | Provider Relationship | Regulatory Compliance, including FDA, DEA and HIPAA | Telehealth and Telemedicine | Telehealth and Telemedicine | White Collar Criminal Defense & Government Investigations | White Collar Defense and Government Investigation

The Federal Trade Commission (“FTC”) recently enforced its Health Breach Notification Rule (“Rule”) for the very first time. The FTC issued a $1.5 million civil penalty to GoodRx and imposed restrictions on the company’s future handling of... Read More
All types of single and multi-specialty medical practice groups | Articles | Behavioral Health Practitioners | Data Transactions | Dispensing Physician Practices and Dispensing Physicians | Drug and Device Advertising, Marketing & Promotion Legal Review | Healthcare Practice Compliance | HIPAA Compliance | Hospitals and Healthcare Systems | Laboratories | Management Services Organizations (MSO) | Medical Practice Representation | Physicians and Medical Practices of all Specialties | Professional Practice Representation | Telehealth and Telemedicine | Telehealth and Telemedicine

As the cost of health care continues to rise, the presence and use of prescription discount cards has increased as well. Prescription discount cards – such as GoodRx or SingleCare – purport to offer patients access to various forms of discounts... Read More
Articles | Chain Pharmacies | Community, Retail Pharmacies | Drug and Device Advertising, Marketing & Promotion Legal Review | Life Sciences | Pharmacy Law | Specialty Pharmacies

Recently, three operators of a Wisconsin CBD dispensary were arrested and are awaiting felony drug charges after failing to comply with the state law.  The investigation into the dispensary began when two minors consumed a CBD-related products... Read More
Articles | Drug and Device Advertising, Marketing & Promotion Legal Review | Life Sciences | News | Regulatory Compliance, including FDA, DEA and HIPAA | White Collar Criminal Defense & Government Investigations

On February 4, 2021, the Attorneys General of 47 states announced a $573 million joint settlement with the global consulting firm McKinsey & Company. The settlement, in which McKinsey did not admit wrongdoing, was predicated on McKinsey’s... Read More
Articles | Drug and Device Advertising, Marketing & Promotion Legal Review | Regulatory Compliance, including FDA, DEA and HIPAA | White Collar Criminal Defense & Government Investigations

Last week, the U.S. Court of Appeals for Second Circuit ruled that the Food and Drug Administration (FDA) cannot prosecute pharmaceutical manufacturers’ representatives for speech promoting the lawful, off-label use of an FDA-approved drug.  The... Read More
Drug and Device Advertising, Marketing & Promotion Legal Review | Life Sciences | Pharmacy Law | Regulatory Compliance, including FDA, DEA and HIPAA | Traditional Compounding Pharmacies (503A)

One of the fastest growing and hottest topics among compounding pharmacies is the marketing of compounded pharmaceuticals by pharmacies to physician groups. More compound pharmacies are marketing directly to area physicians, but our experience shows... Read More
Articles | Drug and Device Advertising, Marketing & Promotion Legal Review | Life Sciences | Pharmacy Law | Traditional Compounding Pharmacies (503A)